These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18637941)

  • 1. Huntington's disease-like 2 and apparent ancestry.
    Rodrigues GG; Teive HA; Tumas V
    Clin Genet; 2009 Feb; 75(2):207; author reply 208. PubMed ID: 18637941
    [No Abstract]   [Full Text] [Related]  

  • 2. Huntington's disease-like 2 in Brazil--report of 4 patients.
    Rodrigues GG; Walker RH; Brice A; Cazeneuve C; Russaouen O; Teive HA; Munhoz RP; Becker N; Raskin S; Werneck LC; Junior WM; Tumas V
    Mov Disord; 2008 Nov; 23(15):2244-7. PubMed ID: 18816802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
    Semaka A; Warby S; Leavitt BR; Hayden MR
    Mov Disord; 2008 Sep; 23(12):1794-5; author reply 1793. PubMed ID: 18548612
    [No Abstract]   [Full Text] [Related]  

  • 4. Huntington disease: a tale of two genes.
    Lahiri N; Tabrizi SJ
    Neurology; 2009 Oct; 73(16):1254-5. PubMed ID: 19776377
    [No Abstract]   [Full Text] [Related]  

  • 5. Does CAG repeat number predict the rate of pathological changes in Huntington's disease?
    Rosenblatt A; Margolis RL; Becher MW; Aylward E; Franz ML; Sherr M; Abbott MH; Lian KY; Ross CA
    Ann Neurol; 1998 Oct; 44(4):708-9. PubMed ID: 9778276
    [No Abstract]   [Full Text] [Related]  

  • 6. [Huntington's disease, 1996].
    Jiménez-Jiménez FJ
    Med Clin (Barc); 1997 May; 108(18):696-7. PubMed ID: 9324585
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
    Reynolds N
    Mov Disord; 2008 Sep; 23(12):1795-6; author reply 1793. PubMed ID: 18548610
    [No Abstract]   [Full Text] [Related]  

  • 8. [Huntington's disease gene: molecular genetics and molecular biology].
    Kanazawa I
    No To Shinkei; 1996 Apr; 48(4):333-44. PubMed ID: 8679330
    [No Abstract]   [Full Text] [Related]  

  • 9. Expanded CAG repeats in the crosshairs.
    Aronin N
    Nat Biotechnol; 2009 May; 27(5):451-2. PubMed ID: 19430450
    [No Abstract]   [Full Text] [Related]  

  • 10. Huntington's disease presenting as postsurgical psychosis.
    Paganoni S; Naidech AM; Opal P
    Mov Disord; 2007 Jun; 22(8):1209-10. PubMed ID: 17443707
    [No Abstract]   [Full Text] [Related]  

  • 11. Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease.
    Pang TY; Du X; Zajac MS; Howard ML; Hannan AJ
    Hum Mol Genet; 2009 Feb; 18(4):753-66. PubMed ID: 19008301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Huntington's disease in Slovenia.
    Peterlin B; Kobal J; Teran N; Flisar D; Lovrecić L
    Acta Neurol Scand; 2009 Jun; 119(6):371-5. PubMed ID: 18976322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism.
    Wong HK; Bauer PO; Kurosawa M; Goswami A; Washizu C; Machida Y; Tosaki A; Yamada M; Knöpfel T; Nakamura T; Nukina N
    Hum Mol Genet; 2008 Oct; 17(20):3223-35. PubMed ID: 18658163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease.
    Giampà C; Middei S; Patassini S; Borreca A; Marullo F; Laurenti D; Bernardi G; Ammassari-Teule M; Fusco FR
    Eur J Neurosci; 2009 Mar; 29(5):902-10. PubMed ID: 19291221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR-spectroscopic findings in juvenile-onset Huntington's disease.
    Reynolds NC; Prost RW; Mark LP; Joseph SA
    Mov Disord; 2008 Oct; 23(13):1931-5. PubMed ID: 18759332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of CAG repeats in normal and Huntington's disease patients in Israel.
    Gazit E; Lubomirov L; Munakov O; Topper A; Frydman M; Fried K; Borochovitz Z; Dangoor N; Bogolubov A; Carp HJ
    Clin Genet; 1998 Sep; 54(3):250-1. PubMed ID: 9788733
    [No Abstract]   [Full Text] [Related]  

  • 17. [The advances in research on phosphorylation of polyglutamine disease].
    Zhou YF; Jiang H; Tang JG; Tang BS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):414-7. PubMed ID: 18683139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of Huntington's disease.
    MacDonald ME
    Results Probl Cell Differ; 1998; 21():47-75. PubMed ID: 9670314
    [No Abstract]   [Full Text] [Related]  

  • 19. Inexpressible trinucleotides.
    McClellan J; Newbury S
    Nature; 1996 Feb; 379(6564):396. PubMed ID: 8559241
    [No Abstract]   [Full Text] [Related]  

  • 20. The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system.
    Chiang MC; Chen HM; Lai HL; Chen HW; Chou SY; Chen CM; Tsai FJ; Chern Y
    Hum Mol Genet; 2009 Aug; 18(16):2929-42. PubMed ID: 19443488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.